The pharmaceutical industry export market share in Singapore is projected to grow steadily from 2024 to 2028. The market share stood at 1.38 in 2023. The year-on-year variation indicates that between 2024 and 2025, the market share increases by 0.72%, and between 2025 and 2026, it grows by 0.71%. For 2026 to 2027, the rise is 0.71%, and from 2027 to 2028, it shows an increment of 0.70%. Over the last two years (2023-2025), the average year-on-year increase is approximately 0.72%, and the compound annual growth rate (CAGR) over the last five years (2023-2028) is around 0.72%. The consistent growth reflects a stable market expansion trend.
Future trends to watch for include potential impacts from advancements in pharmaceutical technologies, regulatory changes, new trade policies, and global healthcare demands. Increased collaboration between Singapore's pharmaceutical firms and international companies may also fuel further growth and innovation in the sector.
